Ha Yeon Park

Title: Ha Yeon Park: Innovator in Cancer Detection and Body Measurement Technologies

Introduction

Ha Yeon Park is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the fields of cancer detection and body measurement technologies. With a total of 2 patents, his work is paving the way for advancements in medical diagnostics and treatment.

Latest Patents

One of Ha Yeon Park's latest patents is an antibody binding specifically to ECL-2 of claudin 3, along with its functional fragments. This invention relates to the use of the antibody in cancer cell detection, diagnosis, imaging, and treatment applications. The antibody includes a characteristic CDR sequence that exerts remarkable effects in these uses, particularly in anticancer applications and in the development of antibody-drug conjugates (ADCs) and CAR-expressing immune cells.

Another notable patent is a system and method for measuring body information, posture information, and range of motion. This system utilizes a three-dimensional (3D) depth camera to create a skeleton image of a subject. It specifies feature points corresponding to the subject's joints and generates connection lines to evaluate posture information and measure joint motion range.

Career Highlights

Ha Yeon Park is currently associated with Abion Inc., where he continues to innovate and develop new technologies. His work is instrumental in enhancing the capabilities of medical diagnostics and therapeutic interventions.

Collaborations

He collaborates with notable colleagues, including Jae Hoon Jeong and Young Kee Shin, who contribute to his research and development efforts.

Conclusion

Ha Yeon Park's innovative work in antibody development and body measurement systems showcases his commitment to advancing medical technology. His contributions are expected to have a lasting impact on cancer treatment and patient care.